Default object view. Click to create a custom template, Node ID: 169182, Object ID: 101435

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Br...

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer: A Randomized Clinical Trial

Tags: Early Early , Locally advanced Locally advanced , Metastatic Metastatic

No relation

Yes

No relation

No

03/01/2017 3:30 pm

No